查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1371965

全球生物感测器市场，到 2030 年的市场预测：按类型、产品、技术、用途和地区进行的全球分析

Biosensor Market Forecasts to 2030 - Global Analysis By Type (Embedded Device, Sensor Patch and Other Types), Product (Non-wearable Biosensors and Wearable Biosensors), Technology, Application and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球生物感测器市场规模为294.8亿美元，预计2030年将达到574.4亿美元，预测期内年复合成长率为10.0%。

生物感测器是一种用于感测或检测生物物质（主要是生物分子和细菌）的存在或浓度的医疗设备。它是一种可以将生物反应转化为电讯号的分析工具。食品和饮料、环境监测、家庭护理诊断和其他奈米机械生物感测器只是生物感测器应用的几个领域。

根据国际糖尿病联盟的数据，糖尿病正以每年约 8.0% 的速度成长。到 2035 年，预计将有超过 5.9 亿人患有糖尿病，这意味着在整个预测期内市场将快速扩张。

生物感测器在医疗领域的广泛应用

生物感测器具有特殊的标准，即疾病预后和患者生存取决于早期和准确的疾病诊断。近年来，对简单、一次性、易于使用、经济高效且响应时间快的设备的需求量很大。用于自我检查、即时检测和血糖监测的生物感测器在实验室中使用和商业性开发。这些生物感测器使用电化学和光学传输模式来检测葡萄糖、尿素、肌酸酐、乳酸和其他物质。此外，生物感测器的应用可以在医疗保健领域的许多领域找到，例如癌症、糖尿病和循环系统疾病。随着这些疾病在全球范围内的患病增加，越来越多地使用生物感测器来早期检测这些疾病。生物感测器非常适合医院、家庭患者和非医院环境中的看护者的新用途，从而推动了生物感测器的使用。

高成本

生物感测器技术的开发、生产和部署需要复杂的製程、专用材料和先进的製造技术，这增加了整体成本。这些成本构成了普及的障碍，特别是在资源有限的医疗机构和成本效益敏感的行业。负担得起对于生物感测器更广泛地传播和融入各种用途普及，为了克服这一市场抑制因素并推动市场成长，透过技术进步和简化製造流程来降低成本增加，努力减少这一点至关重要。

製药业对生物感测器的需求不断增长

生物感测器在製药业中发挥重要作用，有助于药物开发、监测和品管。在药物开发中，生物感测器用于研究潜在药物化合物与生物分子的相互作用，帮助鉴定和最佳化候选药物。在药物传递系统中，生物感测器有助于最佳化给药并确保精确的药物释放，从而提高治疗效果。製药业的品管在很大程度上依赖生物感测器进行批量测试和验证。生物感测器可准确检测和定量特定生物分子，确保药品的纯度、效力和稳定性。因此，生物感测器为製药业提供了支持药物研发、开发和品质保证的宝贵工具，最终有助于医疗保健的进步和改善患者的治疗结果。

资料隐私问题

资料隐私问题是生物感测器市场的主要抑制因素。生物感测器收集和传输与健康相关的敏感资料，引发了对资料隐私和安​​全的担忧。由于担心个人健康资讯可能被滥用或诈欺访问，使用者越来越不愿意采用生物感测器，尤其是穿戴式装置。更严格的资料隐私法规和对这些问题的认识的提高将影响使用者的信任和接受度。因此，透过有效的资料加密、开放的资料处理实践以及遵守严格的隐私法来解决这些问题，将减轻人们的担忧，并鼓励生物感测器在医疗保健和其他行业的广泛采用，对此的推广极为重要。

COVID-19 的影响

COVID-19的爆发对全球生物感测器市场产生了重大影响。为了因应新型冠状病毒肺炎（COVID-19）疫情，许多学术机构和重要企业显着加强了生物感测器的研发力道。例如，根据美国科学促进会（AAAS）介绍，瑞士联邦材料科学技术研究所和苏黎世联邦理工学院的王靖及其团队开发了一种可以特异性识别SARS-CoV-2的POC生物感测器。曾做过。在临床诊断中使用这种感测器来即时监测空气中的病毒量，可以取代但不能取代传统的实验室检测。同样，为了开发用于 COVID-19 测试的生物感测器，电子机械系统和感测器製造商 Rogue Valley Microdevices 正在与 Chaldea Bio & Hemics 等阶段公司合作。因此，这些要素预计将在整个预测期内推动市场扩张。

嵌入式设备领域预计将在预测期内成为最大的领域

由于医疗保健、环境监测、食品和饮料以及家用电子电器等多个行业对嵌入式生物感测器的需求大幅增长，嵌入式设备领域预计将占据最大份额。嵌入式设备是生物感测器的重要子集，它将生物感测器技术整合到各种系统、产品或平台中，增强其功能并实现即时监控和分析。此外，这些生物感测器还可应用于糖尿病管理的连续血糖监测、穿戴式健康追踪器、环境污染监测和食品产业的智慧包装。

预计医疗保健领域在预测期内年复合成长率最高

预计医疗保健领域在预测期内将出现良好成长。生物感测器市场的医疗保健领域正在对患者照护、疾病管理和诊断产生变革性影响。生物感测器具有广泛的应用，包括糖尿病的血糖监测、心臟生物标记检测、怀孕检测、感染疾病诊断和药物水平监测。一项重要的进步是穿戴式生物感测器的开发，它有助于对生命征象、血糖水平和其他健康参数进行连续、非侵入性监测。除此之外，这些穿戴式装置还为患者和医疗保健专业人员提供有价值的资料，从而实现对慢性病的主动管理和及时干预。医疗保健领域是一个重要且不断成长的细分市场，有可能彻底改变医疗保健服务并改善患者的治疗结果。

比最大的地区

由于人口众多且各种文明病的发生率不断上升，亚太地区在估计期间占据了最大的市场占有率。该地区对家庭医疗保健、定点医疗服务和其他成人医疗保健业务的需求不断增加，政府也寻求透过开发门诊病人护理模式来减少住院时间。此外，还有一些配合措施。各国政府、世界卫生组织和克林顿健康倡议公司（CHAI）等组织发起的一系列卫生倡议也推动了该地区的统计数据。此外，在提供区域资料的预测分析时，还将考虑全球品牌的存在和可用性、由于本地和国家品牌的竞争或多或少而面临的挑战、国内关税的影响、贸易路线等。完成。

复合年复合成长率最高的地区：

预计北美在预测期内将实现盈利成长。该地区越来越多地使用生物感测器来追踪食品品质指标，预计将支持市场成长。电子健康记录（EMR）市场渗透率的上升和小型化诊断设备的市场开拓预计将在预测期内推动市场扩张。此外，美国《清洁空气法》、《水污染控制法》和《国家环境政策法》的推出预计将扩大北美市场扩张的机会。此外，北美对 POC 技术的需求不断增长，以及对快速、简单、准确、便携式和低成本分析仪器的关注，将推动该地区生物感测器市场的成长。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究来源
    • 主要研究来源
    • 二次研究来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球生物感测器市场：按类型

  • 嵌入式装置
  • 感应器贴片
  • 其他类型

第6章全球生物感测器市场：按产品

  • 非穿戴式生物感测器
  • 穿戴式生物感测器

第7章全球生物感测器市场：依技术分类

  • 电化学生物感测器
  • 压电生物感测器
  • 奈米机械生物感测器
  • 光学生物感测器
  • 热生物感测器
  • 其他技术

第8章全球生物感测器市场：依用途

  • 医疗测试
    • 血糖测试
    • 血气分析
    • 胆固醇测试
    • 怀孕测试
    • 传染病检查
  • 药物研发
  • 食物中毒
  • 农业检测
  • 工业製程
  • 污水处理
  • 卫生保健
  • 法医学/生物防御
  • 食品/饮料
  • 即时检测
  • 研究
  • 其他用途

第9章全球生物感测器市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Bio-rad Laboratories
  • Nova biomedical
  • Acon laboratories
  • Eastprint incorporated
  • SD biosensor
  • Medtronic
  • Universal Biosensors
  • Conductive technologies
  • F. Hoffmann-La Roche Ltd
  • Innovative Sensor Technology AG
  • Pinnacle Technology
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Biosensors International Group, Ltd
  • Dexcom, Inc.
  • QTL Biosystems
  • Danaher Corporation
  • DuPont Biosensor Materials
  • Johnson & Johnson
Product Code: SMRC24022

According to Stratistics MRC, the Global Biosensor Market is accounted for $29.48 billion in 2023 and is expected to reach $57.44 billion by 2030 growing at a CAGR of 10.0% during the forecast period. Biosensors are medical devices that are used primarily to sense or detect the presence or concentration of biological material, such as a biomolecule or a bacterium. They are analytical tools that can transform a biological reaction into an electrical signal. Food and beverages, environmental monitoring, home care diagnostics, and other nanomechanical biosensors are just a few areas where biosensors are used.

According to the International Diabetic Federation, diabetes is rising at an annual rate of about 8.0 percent. More than 590 million people are expected to develop diabetes by 2035, implying that the market would increase rapidly throughout the projected period.

Market Dynamics:

Driver:

Extensive biosensor applications in medical fields

Biosensors have specialised criteria, which include that the prognosis of diseases and the survival of patients depend on an early and accurate disease diagnosis. Simple, disposable, user-friendly, and cost-effective devices with quick response times have become much more in demand in recent years. In laboratories, biosensors for self-testing, point-of-care testing, and glucose monitoring are being used and commercially developed. These biosensors measure glucose, urea, creatinine, lactate, and other substances using electrochemical and optical modes of transduction. Moreover, applications for biosensors can be found in many areas of the healthcare sector, including cancer, diabetes, and cardiovascular conditions. The use of biosensors for these diseases' early detection has increased as their prevalence around the globe has increased. Biosensors are ideal for new applications in hospitals, by patients at home, and by carers in non-hospital settings, thus boosting the use of biosensors.

Restraint:

High cost

The development, production, and implementation of biosensor technology involve complex processes, specialized materials, and advanced manufacturing techniques, driving up the overall cost. These expenses pose a barrier to widespread adoption, especially in resource-limited healthcare settings and industries sensitive to cost-efficiency. Affordability is crucial for broader accessibility and integration of biosensors into various applications, and efforts to mitigate costs through technological advancements and streamlined manufacturing processes are essential to overcoming this restraint and promoting market growth.

Opportunity:

Rising demand for biosensors in the pharmaceutical industry

Biosensors have a vital role in the pharmaceutical industry, contributing to drug development, monitoring, and quality control. During drug development, biosensors are employed to study the interactions between potential drug compounds and biological molecules, aiding in the identification and optimisation of drug candidates. In drug delivery systems, biosensors assist in optimising dosages and ensuring precise drug release, enhancing therapeutic outcomes. Quality control within the pharmaceutical industry heavily relies on biosensors for batch testing and validation. Biosensors can accurately detect and quantify specific biomolecules, ensuring the purity, potency, and stability of drugs. Thus, biosensors offer invaluable tools in the pharmaceutical sector, supporting drug discovery, development, and quality assurance, ultimately contributing to the advancement of healthcare and the improvement of patient outcomes.

Threat:

Data privacy concerns

Data privacy concerns present a significant restraint in the biosensor market. As biosensors collect and transmit sensitive health-related data, there's growing apprehension regarding data privacy and security. Users worry about potential misuse or unauthorised access to their personal health information, leading to reluctance to adopt biosensors, particularly wearables. Stricter data privacy regulations and increasing awareness of these concerns impact user trust and acceptance. Therefore, it is crucial to reduce concerns and promote a wider adoption of biosensors in healthcare and other industries by addressing these issues through effective data encryption, openness in data handling practices, and adherence to strict privacy legislation.

COVID-19 Impact

The COVID-19 epidemic had a huge impact on the world biosensor market. Numerous academic institutions and significant businesses have significantly raised their biosensor research and development in response to the COVID-19 epidemic. For instance, Jing Wang and his team at the Swiss Federal Laboratories for Materials Science and Technology and ETH Zurich have created a point-of-care biosensor that can specifically identify SARS-CoV-2, according to the American Association for the Advancement of Science (AAAS). The use of this sensor for clinical diagnosis and real-time monitoring of virus content in the air offers an alternative to traditional laboratory testing but does not replace it. Similarly, to create biosensors for COVID-19 testing, Rogue Valley Microdevices-a producer of microelectromechanical systems and sensors-is collaborating with early-stage companies like Cardea Bio & Hememics. Therefore, it is projected that these factors will spur market expansion throughout the forecast period.

The Embedded Device segment is expected to be the largest during the forecast period

The Embedded Device segment is estimated to hold the largest share, due to the significant surge in demand for embedded biosensors across multiple industries, such as healthcare, environmental monitoring, food and beverage, and consumer electronics. Embedded devices, a crucial subset of biosensors, involve the integration of biosensor technology into various systems, products, or platforms, enhancing their functionality and enabling real-time monitoring and analysis. Furthermore, these biosensors find applications in continuous glucose monitoring for diabetes management, wearable health trackers, environmental pollution monitoring, and smart packaging in the food industry, among others.

The Healthcare segment is expected to have the highest CAGR during the forecast period

The Healthcare segment is anticipated to have lucrative growth during the forecast period. The healthcare segment of the biosensors market is witnessing a transformative impact on patient care, disease management, and diagnostics. Biosensors have found extensive applications in glucose monitoring for diabetes, cardiac biomarker detection, pregnancy testing, infectious disease diagnosis, and drug-level monitoring. One of the significant advancements is the development of wearable biosensors, which facilitate continuous and non-invasive monitoring of vital signs, glucose levels, and other health parameters. In addition to this, these wearables provide valuable data to both patients and healthcare professionals, enabling proactive management of chronic conditions and timely interventions. With the potential to revolutionise healthcare delivery and improve patient outcomes, biosensors in the healthcare sector represent a vital and expanding market segment.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period, due to the region's vast population base and rising rates of various lifestyle disorders. Increasing demand for home healthcare, point-of-care services and other adult-focused healthcare enterprises in this region, as well as government initiatives to reduce hospital stays by developing outpatient care models. Regional statistics are also being fuelled by the launch of numerous health initiatives by national governments, the WHO, and organisations like Clinton Health Access Initiative, Inc. (CHAI). Additionally, the presence and availability of global brands and the challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the region data.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period. Increased use of biosensors in this area for tracking food quality indicators is anticipated to support market growth. A rise in the market penetration of electronic medical records (EMR) and the development of miniaturised diagnostic equipment are predicted to drive market expansion over the forecasted period. In addition, the existence of the Clean Air Act, Clean Water Act, and National Environmental Policy Act in the U.S. is expected to open up opportunities for market expansion in North America. Moreover, the increase in demand for POC technologies in North America and the focus on rapid, simple, accurate, portable, and low-cost analytical instruments propel the market growth for the biosensors market in the region.

Key players in the market

Some of the key players in the Biosensor Market include: Bio-rad Laboratories, Nova biomedical, Acon laboratories, Eastprint incorporated, SD biosensor, Medtronic, Universal Biosensors, Conductive technologies, F. Hoffmann-La Roche Ltd, Innovative Sensor Technology AG, Pinnacle Technology, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Biosensors International Group, Ltd, Dexcom, Inc., QTL Biosystems, Danaher Corporation, DuPont Biosensor Materials and Johnson & Johnson.

Key Developments:

In April 2023, Medtronic plc announced that the US FDA had approved its 'MiniMed 780G' system with the Guardian 4 sensor requiring no fingersticks while in SmartGuard technology. The system provides insulin to account for situations where users occasionally forget to bolus or underestimate the number of carbs in their meal. It has been approved for users of and above seven years of age with type 1 diabetes.

In March 2022, Nova Biomedical launched the Nova Max Pro Creatinine/eGFR Meter System, a tool for improving kidney care through kidney function screening and early kidney disease detection in POC settings outside the hospital, in all CE countries. The Nova Max Pro meter and creatinine biosensor measure blood creatinine and calculate estimated glomerular filtration rate (eGFR) from a 1.2 microliter capillary fingerstick blood sample in 30 seconds.

In January 2022, Roche and Sysmex signed a Global Business Partnership Agreement (GBP) to supply hematological diagnostic services. Using IT technology, the new cooperation aims to enhance clinical decision-making and consumer experience. This long-standing, fruitful collaboration is still going strong, offering hematological diagnostic improvements to labs all over the world.

Types Covered:

  • Embedded Device
  • Sensor Patch
  • Other Types

Products Covered:

  • Non-wearable Biosensors
  • Wearable Biosensors

Technologies Covered:

  • Electrochemical Biosensors
  • Piezoelectric Biosensors
  • Nanomechanical Biosensors
  • Optical Biosensors
  • Thermal Biosensors
  • Other Technologies

Applications Covered:

  • Medical Testing
  • Drug discovery
  • Food Toxicity
  • Agricultural Testing
  • Industrial Process
  • Wastewater Treatment
  • Healthcare
  • Forensic and Biodefense
  • Food & Beverages
  • Point of care testing
  • Research laboratories
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biosensor Market, By Type

  • 5.1 Introduction
  • 5.2 Embedded Device
  • 5.3 Sensor Patch
  • 5.4 Other Types

6 Global Biosensor Market, By Product

  • 6.1 Introduction
  • 6.2 Non-wearable Biosensors
  • 6.3 Wearable Biosensors

7 Global Biosensor Market, By Technology

  • 7.1 Introduction
  • 7.2 Electrochemical Biosensors
  • 7.3 Piezoelectric Biosensors
  • 7.4 Nanomechanical Biosensors
  • 7.5 Optical Biosensors
  • 7.6 Thermal Biosensors
  • 7.7 Other Technologies

8 Global Biosensor Market, By Application

  • 8.1 Introduction
  • 8.2 Medical Testing
    • 8.2.1 Blood glucose testing
    • 8.2.2 Blood gas analysis
    • 8.2.3 Cholesterol testing
    • 8.2.4 Pregnancy testing
    • 8.2.5 Infectious disease testing
  • 8.3 Drug discovery
  • 8.4 Food Toxicity
  • 8.5 Agricultural Testing
  • 8.6 Industrial Process
  • 8.7 Wastewater Treatment
  • 8.8 Healthcare
  • 8.9 Forensic and Biodefense
  • 8.10 Food & Beverages
  • 8.11 Point of care testing
  • 8.12 Research laboratories
  • 8.13 Other Applications

9 Global Biosensor Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Bio-rad Laboratories
  • 11.2 Nova biomedical
  • 11.3 Acon laboratories
  • 11.4 Eastprint incorporated
  • 11.5 SD biosensor
  • 11.6 Medtronic
  • 11.7 Universal Biosensors
  • 11.8 Conductive technologies
  • 11.9 F. Hoffmann-La Roche Ltd
  • 11.10 Innovative Sensor Technology AG
  • 11.11 Pinnacle Technology
  • 11.12 Abbott Laboratories
  • 11.13 Thermo Fisher Scientific Inc.
  • 11.14 Siemens Healthineers AG
  • 11.15 Biosensors International Group, Ltd
  • 11.16 Dexcom, Inc.
  • 11.17 QTL Biosystems
  • 11.18 Danaher Corporation
  • 11.19 DuPont Biosensor Materials
  • 11.20 Johnson & Johnson

List of Tables

  • Table 1 Global Biosensor Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Biosensor Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Biosensor Market Outlook, By Embedded Device (2021-2030) ($MN)
  • Table 4 Global Biosensor Market Outlook, By Sensor Patch (2021-2030) ($MN)
  • Table 5 Global Biosensor Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 6 Global Biosensor Market Outlook, By Product (2021-2030) ($MN)
  • Table 7 Global Biosensor Market Outlook, By Non-wearable Biosensors (2021-2030) ($MN)
  • Table 8 Global Biosensor Market Outlook, By Wearable Biosensors (2021-2030) ($MN)
  • Table 9 Global Biosensor Market Outlook, By Technology (2021-2030) ($MN)
  • Table 10 Global Biosensor Market Outlook, By Electrochemical Biosensors (2021-2030) ($MN)
  • Table 11 Global Biosensor Market Outlook, By Piezoelectric Biosensors (2021-2030) ($MN)
  • Table 12 Global Biosensor Market Outlook, By Nanomechanical Biosensors (2021-2030) ($MN)
  • Table 13 Global Biosensor Market Outlook, By Optical Biosensors (2021-2030) ($MN)
  • Table 14 Global Biosensor Market Outlook, By Thermal Biosensors (2021-2030) ($MN)
  • Table 15 Global Biosensor Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 16 Global Biosensor Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Biosensor Market Outlook, By Medical Testing (2021-2030) ($MN)
  • Table 18 Global Biosensor Market Outlook, By Blood glucose testing (2021-2030) ($MN)
  • Table 19 Global Biosensor Market Outlook, By Blood gas analysis (2021-2030) ($MN)
  • Table 20 Global Biosensor Market Outlook, By Cholesterol testing (2021-2030) ($MN)
  • Table 21 Global Biosensor Market Outlook, By Pregnancy testing (2021-2030) ($MN)
  • Table 22 Global Biosensor Market Outlook, By Infectious disease testing (2021-2030) ($MN)
  • Table 23 Global Biosensor Market Outlook, By Drug discovery (2021-2030) ($MN)
  • Table 24 Global Biosensor Market Outlook, By Food Toxicity (2021-2030) ($MN)
  • Table 25 Global Biosensor Market Outlook, By Agricultural Testing (2021-2030) ($MN)
  • Table 26 Global Biosensor Market Outlook, By Industrial Process (2021-2030) ($MN)
  • Table 27 Global Biosensor Market Outlook, By Wastewater Treatment (2021-2030) ($MN)
  • Table 28 Global Biosensor Market Outlook, By Healthcare (2021-2030) ($MN)
  • Table 29 Global Biosensor Market Outlook, By Forensic and Biodefense (2021-2030) ($MN)
  • Table 30 Global Biosensor Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 31 Global Biosensor Market Outlook, By Point of care testing (2021-2030) ($MN)
  • Table 32 Global Biosensor Market Outlook, By Research laboratories (2021-2030) ($MN)
  • Table 33 Global Biosensor Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.